Schroeder Thilo
SEC CIK 1776412 · EDGAR
BoughtSold
Most active insiders at RVMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOLDSMITH MARK A | See Remarks, Dir | — | $56.99M |
| 2 | Kelsey Stephen Michael | See Remarks | — | $22.55M |
| 3 | Cislini Jeff | SVP, GC | — | $15.19M |
| 4 | Kim Lorence H. | Dir | — | $14.97M |
| 5 | Horn Margaret A | COO | — | $10.84M |
| 6 | Mancini Anthony | See Remarks | — | $9.05M |
| 7 | Anders Jack | CFO | — | $7.13M |
| 8 | ANDERSON ELIZABETH M | Dir | — | $1.96M |
| 9 | Patel Sushil | Dir | — | $1.05M |
| 10 | Wei Lin | Chief Medical Off | — | $206.2K |
Schroeder Thilo made no open-market trades at RVMD in the last 12 months.
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-12-09 | 2024-12-05 | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | P - Purchase | $46.00 | +1.30M | 760.9K | New | +$60.00M |
| DMI | 2023-11-14 | 2023-11-09 | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | A - Grant | — | +1.46M | 1.15M | New | — |
| MI | 2023-03-10 | 2023-03-07+ | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | P - Purchase | $21.76 | +650.0K | 1.55M | +72% | +$14.15M |
| I | 2022-07-26 | 2022-07-22 | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | P - Purchase | $20.00 | +250.0K | 1.22M | +26% | +$5.00M |
| MI | 2022-03-29 | 2022-03-25+ | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | P - Purchase | $24.79 | +42.7K | 970.6K | +5% | +$1.06M |
| MI | 2022-03-24 | 2022-03-22+ | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | P - Purchase | $23.63 | +232.4K | 864.1K | +37% | +$5.49M |
| MI | 2022-03-21 | 2022-03-17+ | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | P - Purchase | $20.40 | +168.1K | 620.5K | +37% | +$3.43M |
| MI | 2022-03-14 | 2022-03-10+ | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | P - Purchase | $20.63 | +43.5K | 522.6K | +9% | +$897.8K |
| MI | 2022-03-09 | 2022-03-07+ | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | P - Purchase | $18.91 | +246.4K | 384.1K | +179% | +$4.66M |
| DMI | 2022-03-04 | 2020-02-18+ | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | P - Purchase | $26.30 | +1.09M | 2.67M | +69% | +$28.62M |
| DI | 2022-03-04 | 2020-02-18 | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Dir | C - Cnv Deriv | — | +2.12M | 2.12M | New | — |
| I | 2021-10-08 | 2021-10-06 | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $30.15 | -800 | 1.10M | -0.1% | -$24.1K |
| MI | 2021-10-04 | 2021-09-30+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $30.09 | -14.6K | 1.10M | -1% | -$439.8K |
| MI | 2021-09-29 | 2021-09-27+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $30.06 | -7,461 | 1.12M | -0.7% | -$224.3K |
| I | 2021-09-24 | 2021-09-22 | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $30.00 | -100 | 1.12M | -0.0% | -$3,000 |
| I | 2021-09-21 | 2021-09-17 | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $30.03 | -711 | 1.12M | -0.1% | -$21.4K |
| MI | 2021-09-13 | 2021-09-09+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $30.41 | -70.8K | 1.14M | -6% | -$2.15M |
| MI | 2021-09-02 | 2021-08-31+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $30.25 | -46.9K | 1.22M | -4% | -$1.42M |
| MI | 2021-08-30 | 2021-08-26+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $30.45 | -58.8K | 1.28M | -4% | -$1.79M |
| MI | 2021-08-25 | 2021-08-23+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $30.87 | -51.9K | 1.61M | -3% | -$1.60M |
| MI | 2021-08-20 | 2021-08-18+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $33.05 | -30.7K | 1.64M | -2% | -$1.01M |
| MI | 2021-08-17 | 2021-08-13+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $33.89 | -80.5K | 1.68M | -5% | -$2.73M |
| MI | 2021-08-12 | 2021-08-10+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $34.36 | -68.5K | 1.75M | -4% | -$2.35M |
| MI | 2021-08-09 | 2021-08-05+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $36.23 | -77.7K | 1.84M | -4% | -$2.81M |
| MI | 2021-08-04 | 2021-08-02+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $35.05 | -96.1K | 1.95M | -5% | -$3.37M |
| MI | 2021-07-30 | 2021-07-28+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $35.75 | -11.0K | 1.99M | -0.6% | -$394.1K |
| MI | 2021-07-27 | 2021-07-23+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $35.91 | -17.4K | 2.01M | -0.9% | -$623.5K |
| MI | 2021-07-23 | 2021-07-21+ | PMVP | PMV Pharmaceuticals, Inc. | Schroeder Thilo | Dir | S - Sale | $35.82 | -18.9K | 2.02M | -0.9% | -$676.0K |
Purchase Sale Sale after option exercise All abbreviations